Norgestrel Powder
NDC Package 12866-1011-0
Package Information
Norgestrel powders is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a powder delivery system. Marketed by Bayer Ag, this product is identified by NDC 12866-1011.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 12866 - Bayer Ag
- 12866-1011 -
- 12866-1011-0 - 21.784 kg in 1 CONTAINER
- 12866-1011 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 12866-1011-0 identifies a specific commercial package of 21.784 kg in 1 container of Norgestrel (UNFINISHED drug), a bulk ingredient labeled by Bayer Ag. This powder is formulated for use and contains norgestrel as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Ag on May 10, 2017. The current certification is valid through December 31, 2026.
How is this Bayer Ag product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 12866101100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.